Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
| Current Price | ₹2,912.20 |
|---|---|
| Market Cap | ₹36,370 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | 34.5 |
| Return on Equity | 25.39% |
| 52-Week Range | ₹2,329.90 – ₹3,314.90 |
| Beta (1Y) | 0.21 |
| Dividend Yield | 1.92% |
1. Pharmaceuticals-100%
Ajanta Pharma Limited is trading at ₹2,912.20, with a market capitalisation of ₹36,370 Cr.
Ajanta Pharma Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Ajanta Pharma Limited has a P/E of 34.5 and a return on equity of 25.39%.